China Life Private Equity Investment Company Limited
国寿股权
elsewhere's corpus does not cover this subject directly. The bundle contains no entity description, founding details, team information, or strategy overview for China Life Private Equity Investment Company Limited itself.
What the material does show is its investment activity: it has led or joined rounds in XtalPi (2018 B+, 2020 follow-on) , METiS Pharmaceuticals (2022, co-led with PICC Capital) , StepFun's B+ round (early 2025) , and Sudu Tech (by end-2025) , indicating a focus on healthcare, biotech, and AI infrastructure. The name "国寿股权" (China Life Equity Investment / 国寿股权投资) appears interchangeably in deal announcements, suggesting close operational ties with China Life Investment Management , though the bundle does not clarify the exact corporate relationship.
AI-generated — may contain errors, please verify.
Coverage
Zero real-world training data, nearly 100% success rate! Sudu Tech debuts self-developed system #Sudo R1 | Oasis Vitality
Unlocking a New Paradigm in Embodied Artificial Intelligence
$2 Billion Startup SurgeTech's Debut in Embodied AI Is a Blockbuster: Zero Real-World Data, Zero-Shot, 98% First-Attempt Grasp Success Rate | BlueRun Ventures Family Headlines
Sudo Tech's Embodied Model #Sudo R1 Makes Its Debut
CasCade Therapeutics Closes Nearly 500 Million Yuan Major Funding Round, Targeting Nuclear Receptor and GPCR Innovative Drug R&D
Dedicated to becoming a global leader in metabolic disease therapeutics.
StepFun Closes New 5 Billion Yuan Funding Round: Racing for Endpoints, Crunching Numbers, and the Ultra-Marathon Ahead
StepFun has raised 5 billion yuan in fresh funding, setting a new single-round record for the sector over the past 12 months, as the battle for end-user devices heats up.
StepFun's Major "Step": Over 5 Billion Yuan in B+ Round Funding, Qi Yin Formally Appointed Chairman
StepFun's answer is AI + endpoints.
Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
Money, Contradictions, and ESG
*Who Cares Wins*
A Complete Map of China's Industrial Investment: When the Gears of Fate Begin to Turn
Seven sectors, 200 investments, 500 funds — all in nine charts.
SinoChips Technology Closes Hundreds of Millions of RMB in Series D Funding, Doubles Down on New Power Semiconductor Devices
Further increase R&D investment and capacity expansion in areas such as automotive and new energy.
Three Barometers for the Primary Market, for Your Reference
The bilateral order of the primary market is being restructured on both sides.
New Tracks, Interdisciplinary Fields, Down-Market Expansion, Data Infrastructure... Four Companies Raise Nearly 1.2 Billion RMB in Funding | FreeS Family Funding News · Vol 10
Looking forward to working alongside more outstanding founders.
5Y News | METiS Pharmaceuticals Closes Two Consecutive Rounds Raising $150 Million Total
Become an industry innovation leader.
Code Engraved | METiS Pharmaceuticals Announces Two Consecutive Rounds totaling $150 Million
The most advanced pipeline programs are expected to begin pivotal clinical trials in 2023.
Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
XtalPi Closes $46 Million Series B+ Round | FreeS Fund Deal Brief
Empowering drug R&D organizations worldwide.
